Autopsy report · NCT01079637
Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
Cause of deathSlow enrollment
“The study was stopped because there were not enough eligible patients to complete the study.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 3 years before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- AO Clinical Investigation and Publishing Documentation
- Sponsor type
- University, hospital or other
- Conditions
- Diabetes Mellitus 1 or 2; Midfoot Charcot Neuroarthropathy
- Interventions
- Surgery with Midfoot Fusion Bolt; Cast treatment
- Participants
- 1
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma
“The study stopped because patient enrollment requirements were not met.” - Computed Tomography Enterography (CTE) Versus Capsule Endoscopy for Overt, Obscure Gastrointestinal (GI) Bleeding
“The study was stopped before the first patient was enetered due to logistical issues and lack of funding.” - Assessment of Artificial Intelligence Algorithms for ROTEM
“The study was stopped because it was considered unlikely that the required number of patients could be prospectively recruited across the participating study centers.” - Comparing Palliative Radiotherapy With or Without Carboplatin
“The study was stopped due to insufficient recruitment.” - All-On-4® Treatment Concept
“The study stopped as the performance of the study showed insufficient patient recruitment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.